SLC2A1 and Alzheimer disease: Even preclinically, patients with AD show widespread impairment in glucose metabolic rates (Willette et al., 2015), a deficiency associated with decreased levels of GLUT1 and GLUT3 (Liu et al., 2008), which import glucose across the blood-brain barrier and into neurons, respectively.